Center for the Economics of Reproductive HealthAdministrator2024-02-21T21:28:46-05:00

The Center for the Economics of Reproductive Health

The Center for the Economics of Reproductive Health at the Institute for Women’s Policy Research (IWPR) seeks to advance public understanding and awareness of the link between access to reproductive health care services for women and their long-term economic security and well-being. We conduct original research and policy analysis at the intersections of race, ethnicity, class, and reproductive health to improve economic outcomes, and educational and employment opportunities for all women.

FL abortion ban
Florida Six-Week Abortion Ban Goes Into Effect

Thanks to the state courts and legislature, as of May 1, abortion access in Florida is now more restricted than ever under the state’s near-total ban. The impact will resonate throughout the state, harming women and hurting the state economy.  

SCOTUS mife case Mar 24
Supreme Court Known for the Overturn of Roe v. Wade Tackles Medication Abortion, but the Safety and Effectiveness of Mifepristone Is Not in Question

Access to abortion is once again before the Supreme Court as it hears arguments about mifepristone, the medication abortion drug used safely by millions of women over the last 20 years.

Dobbs anniv
“A Year After the Overturn of Roe v. Wade, We Are Only Beginning to See the Harm This Cruel Decision Is Inflicting on Women in America”

IWPR Interim President and CEO Daisy Chin-Lor on the One-Year Anniversary of the Supreme Court's decision in Dobbs

previous arrowprevious arrow
next arrownext arrow

The Continued Fight for Abortion Access in Florida

Last month, the Florida Supreme Court turned back the clock on reproductive justice in a big way when it upheld the state’s six-week abortion ban. Despite the detrimental 15-week ban that has been in effect since the 2022 Dobbs decision, Florida has remained a southern [...]

By Shannon Emmett|May 1, 2024|

Supreme Court Known for the Overturn of Roe v. Wade Tackles Medication Abortion, but the Safety and Effectiveness of Mifepristone Is Not in Question

FOR IMMEDIATE RELEASE March 26, 2024 Contact: William Lutz 202-785-5100 Supreme Court Known for the Overturn of Roe v. Wade Tackles Medication Abortion, but the Safety and Effectiveness of Mifepristone Is Not in Question Washington, D.C. --- The Institute for Women’s Policy Research’s President and [...]

By William Lutz|March 26, 2024|